- gMed - https://clients.gmed.com -

Messages Involving Cannabis or CBD Products Not Permitted in gReminder+™ Tool

Dear Valued Clients:

We are writing to make you aware that the messaging services platform provider for the gReminder+™ tool has informed us that a subset of clients has sent messages that market and promote cannabis or CBD products via Reminders.

Please note: Messages concerning cannabis or CBD products, marketing or otherwise, are not permitted under our platform provider’s acceptable use policies (see below), and we request that you refrain from sending these types of messages.

Attempting to send messages relating to cannabis or CBD products as a subject is contrary to your agreement with ModMed, and may cause your messages to be suspended, or your practice to be suspended from gReminder+ as a whole among other things. The platform provider’s acceptable usage policy states in part:

As a general reminder, your practice’s phone, text, and email message communications to your patients (Business-to-Consumer) are subject to various federal and state laws and regulations. We remind you that communications containing marketing content of any kind in particular are generally subject to heightened requirements and restrictions.

It is your practice’s responsibility to comply with all applicable laws and regulations concerning communications sent through gReminder+.

If you have any questions regarding these requirements or restrictions, please consult with your legal or compliance advisors.

Sincerely,

The ModMed Gastroenterology Team